Issledovanie ADVANCE: vliyanie Noliprela - fiksirovannoy kombinatsii ingibitora APF (Perindoprila) i diuretika (Indapamida) - na razvitie serdechno-sosudistykh oslozhneniy u patsientov s sakharnym diabetom 2 tipa
https://doi.org/10.14341/2072-0351-5952
Abstract
В сентябре 2007 г. в Вене на очередном Европейском конгрессе кардиологов впервые были публично представлены результаты исследования ADVANCE, посвященного предотвращению сердечно-сосудистых осложнений у больных сахарным диабетом 2 типа (СД 2). Решение этой проблемы ? одна из важнейших задач современной медицины. Эпидемия сахарного диабета, захлестывающая сегодняшний мир, ведет к ранней инвалидизации и смертности миллионов таких больных. Как правило, трагические исходы обусловлены сердечно-сосудистыми осложнениями сахарного диабета 2 типа (СД 2), в первую очередь ишемической болезнью сердца.
About the Authors
Marina Vladimirovna Shestakova
Endocrinology Research Centre, Moscow
Russian Federation
Russian Federation
Andrey Alexeevich Aleksandrov
Endocrinology Research Centre, Moscow
Russian Federation
Russian Federation
Natalya Galitsyna
Endocrinology Research Centre, Moscow
Russian Federation
Russian Federation
References
1. ADVANCE trial: presented also at the Hot-line session at the European Congress of Cardiology in Vienna 2007, September 2. http://www.advance-trial.com
2. Patel A; ADVANCE Collaborative Group, MacMahon S, Chalmers J et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; Sep8;370(9590): 829-840
3. Stratton IM, Adler AI, Neil AW, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-412
4. Adler AI, Stratton IM, Neil AW, Yudkin JS, Matthews DR, Cull CA. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: 412-419
5. Adler AI, Stratton IM et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 UK Prospective Diabetes Study Group BMJ 1998 317: 703-713.
6. Tuomilehto J.Controlling glucose and blood pressure in type 2 diabetes BMJ 2000 321: 394-395.
7. Mancia, G., De Backer, G. ESC Committee for Practice Guidelines (CPG) 2007 Guidelines for the Management of Arterial Hypertension:The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 0: ehm236v1-75
8. Leitao, C. B., Canani, L. H., Kramer, C. K., Boza, J. C., Pinotti, A. F., Gross, J. L. Masked Hypertension, Urinary Albumin Excretion Rate, and Echocardiographic Parameters in Putatively Normotensive Type 2 Diabetic Patients. Diabetes Care; 2007 30: 1255-1260 Stults, B., Jones, R. E. (2006). Management of Hypertension in Diabetes. Diabetes Spectr. 19: 25-31
9. Webster MW et al. Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000;355:253-259,
10. Weir M. R. Microalbuminuria and Cardiovascular Disease Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 581 - 590
11. G de P, Pedersen O: Intensive integrated therapy of type 2 diabetes: implications for long-term prognosis. Diabetes 2004;53(suppl 3):S39-S47.
12. Pedersen O, G de PH: Intensified multifactorial intervention and cardiovascular outcome in type 2 diabetes:the Steno-2-study . Metabolism 2003;52:19-23.
13. Кобалава Ж.Д., Моисеев В.С. Лечение и обследование пожилых больных с артериальной гипертонией: представления врачей и реальная практика (по данным Российской научно-практической программы АРГУС) Артериальная гипертензия 2002;Том08/N 5
14. Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. JAMA. 1982 Sep 24;248(12):1465-77.
15. Assmann G, Schulte H. The Prospective Cardiovascular M nster Study: prevalence and prognostic significance of hyperlipidemia in men with systemic hypertension.Am J Cardiol. 1987 May 29;59(14):9G-17G.
16. Hanson L., Zanchetti A. The Hypertension Optimal Treatment (HOT) Study: randomization, risk profiles and early blood pressure results Blood Press.1994; v.3, -322-327
17. Pahor M., M. Psaty B. Meta-analysis of Hypertension Trials in Diabetic Patients Diabetes Care 24:178-180, 2001
18. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes; estimates for year 2000 and projections for 2030. Diabetes Care 2004; 21:1047-53.
19. Blood Pressure Lowering Treatment Trialists Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus. Arch Intern Med 2005; 165:1410-19.
20. Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. Hypertens 2002; 20:1461-64.
21. Stettler C, Allemann S, Juni P, et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials. Am Heart J 2006; 152: 27-38.
22. ADVANCE Management Committee. Rationale and design of the ADVANCE study: a randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus. Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified-Release Controlled Evaluation. J Hyptrtens Suppl 2001; 19; S21-28.
23. Shulz KF, Grimes DA. Multiplicity in randomised trials I: endpoints and treatments. Lancet 2005; 365:1591-95.
Review
For citations:
Shestakova M.V., Aleksandrov A.A., Galitsyna N. Issledovanie ADVANCE: vliyanie Noliprela - fiksirovannoy kombinatsii ingibitora APF (Perindoprila) i diuretika (Indapamida) - na razvitie serdechno-sosudistykh oslozhneniy u patsientov s sakharnym diabetom 2 tipa. Diabetes mellitus. 2008;11(1):81-84. (In Russ.) https://doi.org/10.14341/2072-0351-5952
Views:
7214
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
